Was ist die Webseite?

https://www.facebook.com/168527300321165/

Aspivix

Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von Aspivix, Medizin und Gesundheit, Renens.

10/11/2025

📢 Aspivix auf dem KMS 2025

Wir freuen uns, Ihnen mitteilen zu können, dass Aspivix vom 13. bis 14. November 2025 am Kongress für praktische Gynäkologie und Geburtshilfe (KMS) in der Schweiz teilnehmen wird.

👩‍⚕️ Unsere Kollegin Annika Dunkel, klinischer Vertriebsspezialist, wird uns bei diesem wichtigen Treffen von Fachleuten aus dem Gesundheitswesen vertreten.

Bei Aspivix ist es unsere Mission, Innovation und Mitgefühl in die gynäkologische Versorgung zu bringen. Mit carevix®, CE-gekennzeichneten, atraumatischen Gebärmutterhalsstabilisator, wollen wir Eingriffe wie die Einlage von Intrauterinpessaren sanfter und schmerzarmer machen – und so die Gesundheit von Frauen mit patientenorientierten Lösungen verbessern.

Wir freuen uns darauf, Kontakte zu knüpfen, Neues zu lernen und zu Diskussionen beizutragen, die die Zukunft der Gynäkologie prägen.

Verbinden Sie sich jetzt mit Annika Dunkel ➡️ :
https://www.linkedin.com/in/annika-dunkel/

_______________________________

📢 Aspivix at the KMS 2025

We are pleased to announce that Aspivix will be participating in the Congress for Practical Gynecology and Obstetrics (KMS) in Switzerland from November 13 to 14, 2025.

👩‍⚕️ Our colleague Annika Dunkel, Clinical Sales Specialist, will represent us at this important gathering of healthcare professionals.

At Aspivix, our mission is to bring innovation and compassion to gynecological care. With carevix®, a CE-marked, atraumatic cervical stabilizer, we aim to make procedures such as intrauterine device insertion gentler and less painful—improving women's health with patient-centered solutions.

We look forward to networking, learning new things, and contributing to discussions that will shape the future of gynecology.

Connect now with Annika Dunkel➡️ :
https://www.linkedin.com/in/annika-dunkel/

06/11/2025

𝗪𝗵𝗮𝘁 𝗶𝗳 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗱𝗶𝗱𝗻’𝘁 𝗿𝗲𝗾𝘂𝗶𝗿𝗲 𝗽𝗮𝗶𝗻?

What if the tenaculum wasn’t your only option? At 𝗔𝘀𝗽𝗶𝘃𝗶𝘅, we’re redefining women’s healthcare with innovation that truly cares.💜

Our 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® device uses gentle suction-based technology to stabilize the cervix — offering a smarter, safer, and more compassionate alternative for transcervical procedures.

Healthcare professionals in Los Angeles, Orange County, and New York can now access the exclusive 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® Starter Pack, available at 𝗠𝘆𝗔𝘀𝗽𝗶𝘃𝗶𝘅.𝘂𝘀 - https://myaspivix.us/

Because every woman deserves precision without pain. 💙𝗔𝘀𝗽𝗶𝘃𝗶𝘅 - 𝗖𝗮𝗿𝗲 𝗿𝗲𝗶𝗺𝗮𝗴𝗶𝗻𝗲𝗱.

05/11/2025

What if 9 out of 10 of your patients experienced less pain during procedures?

That’s exactly what healthcare providers report when using 𝗰𝗮𝗿𝗲𝘃𝗶𝘅®.

𝟵/𝟭𝟬 HCPs saw reduced patient discomfort*

𝟵𝟰% of patients were satisfied*

𝟵𝟲% of providers found 𝗰𝗮𝗿𝗲𝘃𝗶𝘅® simple and intuitive*

These aren’t just numbers. They’re real results reshaping women’s health. carevix® empowers clinicians to deliver gentler, more confident care while building stronger patient trust.

Are you ready to redefine patient comfort in your clinic?

👉 Learn more: myaspivix.us

04/11/2025

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗮𝘁 𝘁𝗵𝗲 𝗪𝗛𝗜𝗦 𝗨𝗦𝗔 𝟮𝟬𝟮𝟱 💜

Join our CMO, Ikram Guerd, at the 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗦𝘂𝗺𝗺𝗶𝘁 𝗨𝗦𝗔, where leaders and innovators come together to shape the next era of women’s health.

She will share insights on how to elevate brands in Women’s Health. For too long, discomfort during gynecological care has been accepted as “normal.” As an illustration at Aspivix, we’re changing that narrative. With carevix®, our mission is clear: to make transcervical procedures gentler, more compassionate, and pain-free, empowering both providers and patients alike.

This summit is more than an event, it’s a movement. A space where ideas meet impact, and where women’s comfort and dignity take center stage. Let’s reimagine care, together. 💫

03/11/2025

𝗖𝗮𝗿𝗲𝘃𝗶𝘅® 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗶𝗻 𝗨𝗦𝗔 𝗧𝗼𝗱𝗮𝘆: 𝗔 𝗡𝗲𝘄 𝗘𝗿𝗮 𝗳𝗼𝗿 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗶𝗻 𝘁𝗵𝗲 𝗨.𝗦.💜

We’re thrilled to share that carevix® have been featured in USA Today, in an article titled: “It was named one of health’s best inventions of 2024. It’s finally available in the US.”The piece highlights carevix® as a significant step forward in women’s health, an innovation designed to replace the century-old tenaculum with gentle suction technology that reduces pain and bleeding during transcervical procedures such as IUD insertions.

With recent ACOG guidelines encouraging a patient-centric care and options for pain management for gynecological procedures including IUD insertions, the arrival of carevix® marks a true turning point — one that recognizes women’s pain and redefines what compassionate care can look like.

Now available to medical providers in Southern California and New York, with a national rollout to follow in 2026, carevix® is here to help clinicians deliver safer, more comfortable, and patient-centered care.

💡 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗨𝗦𝗔 𝗧𝗼𝗱𝗮𝘆 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗵𝗲𝗿𝗲 →
https://www.usatoday.com/story/life/health-wellness/2025/10/29/iud-insertion-cervix-health/86962361007/

31/10/2025

✨ Thank you for joining us at the 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗼𝗳 𝗙𝗮𝗺𝗶𝗹𝘆 𝗣𝗹𝗮𝗻𝗻𝗶𝗻𝗴 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟱 𝗶𝗻 𝗣𝗶𝘁𝘁𝘀𝗯𝘂𝗿𝗴𝗵!

We’re grateful for the opportunity to connect with dedicated clinicians and researchers advancing women’s health with patient-centered care.

A special thank-you to everyone who joined a demo, and shared their perspective. Together, we’re changing the story of women’s health.

29/10/2025

Why do we normalize pain?

For too long, women have been told that pain during IUD insertion is “quick and normal.”

But for so many, that pain is unforgettable — and sometimes, even traumatic. It doesn’t have to be this way. Transcervical procedures should prioritize comfort, compassion, and care — not endurance.✨

𝗔 𝗻𝗲𝘄 𝗰𝗵𝗼𝗶𝗰𝗲 𝗶𝘀 𝗰𝗼𝗺𝗶𝗻𝗴 𝘁𝗼 𝗟𝗼𝘀 𝗔𝗻𝗴𝗲𝗹𝗲𝘀, 𝗡𝗲𝘄 𝗬𝗼𝗿𝗸 𝗮𝗻𝗱 𝗢𝗿𝗮𝗻𝗴𝗲 𝗖𝗼𝘂𝗻𝘁𝘆.
One that puts you at the center.

𝗔𝘀𝗽𝗶𝘃𝗶𝘅. 💜

Here to change the story — for good.

27/10/2025

🏆 𝗔𝘀𝗽𝗶𝘃𝗶𝘅 𝗡𝗮𝗺𝗲𝗱 𝗧𝗼𝗽 𝟯 𝗙𝗶𝗻𝗮𝗹𝗶𝘀𝘁 – 𝗦𝗼𝗖𝗮𝗹 𝗔𝗠𝗖𝗛𝗔𝗠 𝗦𝘁𝗲𝘄𝗮𝗿𝗱𝘀𝗵𝗶𝗽 𝗔𝘄𝗮𝗿𝗱 𝟮𝟬𝟮𝟱

We’re proud to share that Aspivix has been selected as one of the 𝗧𝗼𝗽 𝟯 𝗳𝗶𝗻𝗮𝗹𝗶𝘀𝘁𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗔𝘃𝗮𝗻𝘁𝗴𝗮𝗿𝗱𝗲 𝗔𝘄𝗮𝗿𝗱 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝗼𝗻 𝘂𝗻𝗱𝗲𝗿 𝘁𝗵𝗲 𝗦𝗼𝗖𝗮𝗹 𝗔𝗠𝗖𝗛𝗔𝗠 𝗦𝘁𝗲𝘄𝗮𝗿𝗱𝘀𝗵𝗶𝗽 𝗔𝘄𝗮𝗿𝗱 𝟮𝟬𝟮𝟱, organized by the Swiss-American Chamber of Commerce in Southern California.

This recognition highlights our commitment to advancing women’s health through innovation, compassion, and responsible leadership.

At Aspivix, we’re redefining gynecological care with 𝗰𝗮𝗿𝗲𝘃𝗶𝘅® — a clinically tested, 𝗙𝗗𝗔-𝗰𝗹𝗲𝗮𝗿𝗲𝗱, and 𝗖𝗘-𝗺𝗮𝗿𝗸𝗲𝗱 device designed to make procedures like IUD insertions gentler and less painful.

We’re honored to stand alongside other innovators driving meaningful impact in healthcare and beyond.

✨ Thank you to AMCHAM SoCal for recognizing our mission to make women’s healthcare safer, more respectful, and more patient-centered.

🔗 𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗔𝘃𝗮𝗻𝘁𝗴𝗮𝗿𝗱𝗲 𝗔𝘄𝗮𝗿𝗱: https://www.saccla.org/avantgarde-award-2025.html

24/10/2025

Our Aspivix Marketing Team has been recognized a 𝟮𝟬𝟮𝟱 𝗧𝗼𝗽 𝟭𝟬𝟬 𝗠𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 𝗧𝗲𝗮𝗺 𝗔𝘄𝗮𝗿𝗱 𝗪𝗶𝗻𝗻𝗲𝗿 𝗮𝘁 𝘁𝗵𝗲 𝗢𝗻𝗖𝗼𝗻 𝗜𝗰𝗼𝗻 𝗔𝘄𝗮𝗿𝗱𝘀!

This recognition celebrates creativity, innovation, and purpose-driven storytelling — all rooted in one mission:

💜 𝗧𝗼 𝗿𝗲𝗶𝗺𝗮𝗴𝗶𝗻𝗲 𝗰𝗮𝗿𝗲 𝗳𝗼𝗿 𝘄𝗼𝗺𝗲𝗻 𝗲𝘃𝗲𝗿𝘆𝘄𝗵𝗲𝗿𝗲.

Thank you to everyone who supports our journey to bring empathy and innovation together in women’s health.

Aspivix. Care, Reimagined.

Ikram Guerd

23/10/2025

💜Aspivix 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗼𝗻 𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘁𝗶𝗰𝗸𝗲𝗿: 𝗨.𝗦. 𝗟𝗮𝘂𝗻𝗰𝗵 𝗮𝗻𝗱 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝗱 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻.

𝗧𝗵𝗶𝘀 𝗳𝗲𝗮𝘁𝘂𝗿𝗲 𝗶𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗮 𝗺𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 - 𝗶𝘁’𝘀 𝗽𝗿𝗼𝗼𝗳 𝗼𝗳 𝗺𝗼𝗺𝗲𝗻𝘁𝘂𝗺:

Clinical validation and real-world data underpin Carevix’s value-proposition.

A U.S. launch in Southern California and New York as a 1st step aligns with updated guidelines emphasizing pain management in gynecological care.

Ongoing partnerships and expansion plans that amplify our mission globally.

This milestone reflects our commitment to redefining women’s healthcare. With 𝗖𝗮𝗿𝗲𝘃𝗶𝘅®, we’re setting a new standard for transcervical procedures — one that prioritizes both clinical precision and patient comfort.

Together, we are shaping a future where comfort and care go hand in hand.

Thank you to our team, partners, clinicians, and patients who continue to fuel our journey.

🔗 Read the full article: http://startupticker.ch/ – US launch and further validation for Aspivix

Ikram Guerd

22/10/2025

📢 𝗔𝘀𝗽𝗶𝘃𝗶𝘅 𝗮𝘁 𝘁𝗵𝗲 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗼𝗳 𝗙𝗮𝗺𝗶𝗹𝘆 𝗣𝗹𝗮𝗻𝗻𝗶𝗻𝗴 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟱 𝗶𝗻 𝗣𝗶𝘁𝘁𝘀𝗯𝘂𝗿𝗴𝗵

Interested in learning more about 𝗰𝗮𝗿𝗲𝘃𝗶𝘅®?
Want to see a demo?

Clinicians, researchers, and innovators shaping the future of reproductive health, join our team for demos and discussions at the Society of Family Planning (SFP) Annual Meeting 2025, in Pittsburgh, Pennsylvania.

At Aspivix, our mission is to advance patient-centered innovation in women’s healthcare. Through 𝗰𝗮𝗿𝗲𝘃𝗶𝘅® - our clinically tested, FDA-cleared, atraumatic cervical stabilizer — we’re working to make IUD insertions and transcervical procedures gentler, safer, and more respectful.

We look forward to connecting with healthcare professionals, sharing insights, and exploring how innovation can continue to transform reproductive care.

📍𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗲𝘃𝗲𝗻𝘁: https://societyfp.org/learning/annual-meeting/

Ikram Guerd Mathieu Horras Daniela Schardinger

21/10/2025

𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝗮 𝗴𝗲𝗻𝘁𝗹𝗲𝗿 𝗰𝗮𝗿𝗲 𝗳𝗼𝗿 𝗜𝗨𝗗 𝗶𝗻𝘀𝗲𝗿𝘁𝗶𝗼𝗻𝘀 𝗵𝗲𝗿𝗲.💜

Discover how 𝗰𝗮𝗿𝗲𝘃𝗶𝘅® redefines patient comfort without compromising precision or outcomes.

𝗡𝗼𝘄 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗶𝗻 𝗦𝗼𝘂𝘁𝗵𝗲𝗿𝗻 𝗖𝗮𝗹𝗶𝗳𝗼𝗿𝗻𝗶𝗮 𝗮𝗻𝗱 𝗡𝗲𝘄 𝗬𝗼𝗿𝗸.

👉 Book your demo today: myaspivix.us/appointment/2

Aspivix. Care, Reimagined.

Ikram Guerd

Adresse

Webseite

facebook.com

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Aspivix erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Wollen Sie Ihr Praxis zum Top-Klinik in Renens machen?

Kategorie

Medizin und Gesundheit

ASPIVIX

ASPIVIX is a Swiss-based medical device company dedicated to R&D, Manufacturing and Sales of technologies for women’s health.

Our vision is to empower women around the world by driving healthcare innovation in areas that are needed the most, thus making a positive impact in women’s everyday life.

Our flagship product, is a next generation, patent protected vacuum-based cervical device that delivers the same manoeuvrability as the traumatic tenaculum - used 80 million times/year - without the reported patient trauma related to pain, bleeding, tissue tear. We believe that women deserve gentler and more modern methods for procedures in gynecology.

Results from “First in Women” Trial in Switzerland are expected in 2H2020.